Celltrion | 068270 - Ebit

Stock Price
206,000.00
Daily Change
6,000.00 3.00%
Monthly
-15.75%
Yearly
9.93%
Q1 Forecast
195,060.60

Celltrion reported KRW301.04B in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Akebia Therapeutics USD 13.51M 27.82M Mar/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Avita Medical AUD -10.39M 1.72M Dec/2025
Celltrion KRW 301.04B 58.57B Sep/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Moderna USD -857M 597M Dec/2025
Organon & Co USD 388M 28M Sep/2025
Revvity USD 145.83M 47.49M Dec/2025
Tectonic Therapeutic USD -22.33M 4.03M Jun/2025
Viatris USD -157.5M 392M Dec/2025
Xeris Pharmaceuticals USD 7.89M 2.46M Sep/2025